Organix-South launches TheraVeda Immune Support
BOWLING GREEN, Fla. — Organix-South earlier this week launched TheraVeda Immune Support, an herbal blend of turmeric, neem and ginger, plus ashwagandha, guduchi and holy basil to support overall strength and stamina.
The TheraVeda line, which includes seven condition-specific formulas, was developed by Organix-South in partnership with Shrikrishna Phadke, Ayurvedic practitioner and teaching physician.
According to Organix- South founder Autumn Blum, “TheraVeda Immune Support is like an herbal multivitamin with herbs that have been traditionally used to fortify and protect our overall well-being and address the occasional seasonal imbalance. Our Immune Support is a first-reach formula to help build a strong foundation to better respond to stressors, calm the nervous system and promote overall immune intelligence.”
Watson files for approval of generic painkiller
PARSIPPANY, N.J. — Watson Pharmaceuticals is looking to become the first to market a generic version of a painkiller made by Pfizer, the drug maker said Friday.
Watson said it filed a regulatory approval application with the Food and Drug Administration for morphine sulfate and naltrexone hydrochloride extended-release capsules in the 30-mg/1.2-mg, 50-mg/2-mg, 60-mg/2.4-mg, 80-mg/3.2-mg and 100-mg/4-mg strengths. The drug is a generic version of Embeda, made by Pfizer subsidiary King Pharmaceuticals.
Pfizer, King and Alpharma Pharmaceuticals filed a patent infringement suit against Watson Thursday, alleging that Watson’s product violates three patents covering Embeda. Filed under the provisions of the Hatch-Waxman Act of 1984 — the law that created an abbreviated approval pathway for generic pharmaceuticals — the suit puts a stay of final FDA approval of the drug for 30 months, or until the companies settle.
Embeda had sales of about $42 million during the 12-month period ended in August, according to IMS Health.
Survey: Shoppers compelled to buy when armed with online coupons, coupon codes
AUSTIN, Texas — Online coupons and coupon codes could drive sales for businesses, according to a new study.
The research, conducted by Forrester Consulting on behalf of WhaleShark Media, found that among 504 coupon site users surveyed, active coupon users reported not only spent more than less active coupon users ($1,850 versus $1,025), nearly three-quarters of active coupon users (74%) polled said that they more likely would try a new brand if they received a coupon or promotion code, versus 54% of less active coupon users. Additionally, visitors to online coupon sites made 18% more online purchases in the last six months and said they expect to spend 16% more (compared with other shoppers) in the next 12 months.
When it came to how coupons or coupon codes motivated spending, 88% said the promotions helped “close the deal” on their decision to make a purchase; 60% said they would be more likely to reconsider purchasing an item that hadn’t previously bought if they received an online coupon or promotion code. A majority of those surveyed said online coupons and coupon codes boost a company’s brand image (80%) and prompt positive feeling towards companies that offer them (88%).
Although it is known that online coupon use is on the rise, WhaleShark Media, which operates such couponing sites as CouponShare.com, Deals.com, RetailMeNot.com and more, said it commissioned the survey to understand what this meant to those providing the deals (i.e., retailers and suppliers).
“The results are very compelling, suggesting that a mix of creative and effective retailer marketing, coupled with savvy and resourceful shoppers, can dramatically spur shopping activity and retailer sales,” WhaleShark Media CEO Cotter Cunningham said.